Encompass Health Corp/ US29261A1007 /
| 2024-05-16 9:59:55 PM | Chg. -1.67 | Volume | Bid10:01:24 PM | Ask10:00:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 85.39USD | -1.92% | 23,715 Turnover: 1.07 mill. |
79.99Bid Size: 1 | 90.83Ask Size: 1 | 8.58 bill.USD | 0.70% | 24.27 |
Assets
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,310.1000 | 1,391.8000 | 1,517.1000 | 1,634.8000 | 1,959.3000 | ||||||
| Intangible Assets | 419.4000 | 411.3000 | 403.1000 | 443.4000 | 476.3000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | 4,191.5000 | 4,512.9000 | 5,324.9000 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 410.5000 | 443.8000 | 472.1000 | 467.7000 | 506.1000 | ||||||
| Cash and Cash Equivalents | 61.6000 | 40.5000 | 54.4000 | 69.2000 | 94.8000 | ||||||
| Current Assets | 598.7000 | 654.5000 | 702.2000 | 662.1000 | 755.8000 | ||||||
| Total Assets | 4,606.1000 | 4,681.9000 | 4,893.7000 | 5,175 | 6,080.7000 | ||||||
Liabilities
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 61.6000 | 68.3000 | 78.4000 | 90 | 94.6000 | ||||||
| Long-term debt | 3,134.7000 | 2,979.3000 | 2,545.4000 | 2,478.6000 | 3,023.3000 | ||||||
| Liabilities to Banks | 3,134.7000 | 2,979.3000 | 2,545.4000 | 2,478.6000 | 3,023.3000 | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 3,826.8000 | 3,753.2000 | 3,469.1000 | 3,618 | 4,387.6000 | ||||||
| Share Capital | 1.1000 | 1.1000 | 1.1000 | 1.1000 | 1.1000 | ||||||
| Total Equity | 779.3000 | 928.7000 | 1,424.6000 | 1,557 | 1,693.1000 | ||||||
| Minority Interests | 167.9000 | 192.8000 | 242.9000 | 280.3000 | 340.9000 | ||||||
| Total liabilities equity | 4,606.1000 | 4,681.9000 | 4,893.7000 | 5,175 | 6,080.7000 | ||||||
Income Statement
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 3,115.7000 | 3,707.2000 | 3,971.4000 | 4,277.3000 | 4,605 | ||||||
| Depreciation (total) | 139.7000 | 172.6000 | 183.8000 | 199.7000 | 218.7000 | ||||||
| Operating Result | - | - | - | - | - | ||||||
| Interest Income | 142.9000 | 172.1000 | 154.4000 | 147.3000 | 159.7000 | ||||||
| Income Before Taxes | 395.6000 | 482 | 496.4000 | 493.2000 | 562.3000 | ||||||
| Income Taxes | 141.9000 | 163.9000 | 160.6000 | 118.9000 | 115.9000 | ||||||
| Minority Interests Profit | -69.7000 | -70.5000 | -79.1000 | -83.1000 | -87.1000 | ||||||
| Net Income | 181.5000 | 247.6000 | 256.3000 | 292.3000 | 358.7000 | ||||||
Per Share
Cash Flow
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 484.8000 | 605.5000 | 657.2000 | 762.4000 | 635.3000 | ||||||
| Cash Flow from Investing Activities | -1,129.8000 | -245 | -284.5000 | -424.5000 | -657.4000 | ||||||
| Cash Flow from Financing | 639.9000 | -381.6000 | -358.8000 | -321.2000 | 48.2000 | ||||||
| Decrease / Increase in Cash | -5.1000 | -21.1000 | 13.9000 | 16.7000 | 26.1000 | ||||||
| Employees | 34,700 | 35,710 | 29,370 | 30,060 | 31,570 | ||||||
